Retracted: Effects of flavocoxid, a dual inhibitor of COX and 5‐lipoxygenase enzymes, on benign prostatic hyperplasia

Abstract

Our results show that a 'dual inhibitor' of the COX and 5-LOX enzymes, such as flavocoxid, might represent a rational approach to reduce BPH through modulation of eicosanoid production and a caspase-induced apoptotic mechanism.